Expression of a Human IgG4 Antibody, BAB2, with Specificity for the Major Birch Pollen Allergen, Bet v 1 in Escherichia coli: Recombinant BAB2 Fabs Enhance the Allergic Reaction (original) (raw)

Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1

Vincenzo Visco

Journal of immunology (Baltimore, Md. : 1950), 1996

View PDFchevron_right

Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1☆, ☆☆, ★, ★★

Jean-jacques Pin

Journal of Allergy and Clinical Immunology, 1997

View PDFchevron_right

Molecular characterization of human IgG monoclonal antibodies specific for the major birch pollen allergen Bet v 1. Anti-allergen IgG can enhance the anaphylactic reaction

Peter Steinberger

FEBS Letters, 2000

View PDFchevron_right

Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2

Fatima Ferreira

Journal of allergy and …, 1996

View PDFchevron_right

Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG1 and IgG4 against the Major Birch Pollen Allergen Bet v 1

Rodolfo Bianchini

International Journal of Molecular Sciences

View PDFchevron_right

Conversion of grass pollen allergen-specific human IgE into a protective IgG1 antibody

Peter Steinberger

European Journal of Immunology, 2002

View PDFchevron_right

Induction of IgE antibodies with predefined specificity in rhesus monkeys with recombinant birch pollen allergens, Bet v 1 and Bet v 2

Fatima Ferreira

Journal of allergy and …, 1996

View PDFchevron_right

Vaccination for birch pollen allergy Induction of affinity-matured or blocking IgG antibodies does not account for the reduced binding of IgE to Bet v 1

Morten Svenson

Molecular Immunology, 2003

View PDFchevron_right

Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

Guro Gafvelin

International Archives of Allergy and Immunology, 2005

View PDFchevron_right

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy

Michael Breitenbach

Journal of Experimental Medicine, 1996

View PDFchevron_right

Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for …

Fatima Ferreira

The Journal of …, 1996

View PDFchevron_right

T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies

FERAH BUDAK

Journal of Immunology, 2000

View PDFchevron_right

Human recombinant antibody fragments specific for a rye-grass pollen allergen: Characterization and potential applications

lol no

Molecular Immunology, 1996

View PDFchevron_right

Dominant Epitopes and Allergic Cross-Reactivity: Complex Formation Between a Fab Fragment of a Monoclonal Murine IgG Antibody and the Major Allergen from Birch Pollen Bet v 1

osman mirza

The Journal of Immunology, 2000

View PDFchevron_right

Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: A quantitative IgE inhibition study with sera from different populations☆☆☆★★★

Hans Grönlund

Journal of Allergy and Clinical Immunology, 1998

View PDFchevron_right

Confirmation of immuno-reactivity of the recombinant major birch pollen allergen Bet v 1a by affinity-CIEF

Andreas Rizzi

ELECTROPHORESIS, 2009

View PDFchevron_right

Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen

Fatima Ferreira

Journal of allergy and …, 1999

View PDFchevron_right

Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a

Fatima Ferreira

Allergy, 2004

View PDFchevron_right

Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies

Barbara Ballmer-weber

Journal of Allergy and Clinical Immunology, 2011

View PDFchevron_right

High-level expression and purification of the major birch pollen allergen, Bet v 1

Fatima Ferreira

Protein expression and …, 1997

View PDFchevron_right

Dominating IgE-Binding Epitope of Bet v 1, the Major Allergen of Birch Pollen, Characterized by X-ray Crystallography and Site-Directed Mutagenesis

osman mirza

The Journal of Immunology, 2003

View PDFchevron_right

Vaccination for birch pollen allergy

Klaus Bendtzen

Molecular Immunology, 2003

View PDFchevron_right

Engineering, Purification and Applications of His-Tagged Recombinant Antibody Fragments with Specificity for the Major Birch Pollen Allergen, Bet v1

Bashar Abdul Alhani

Biological Chemistry, 2000

View PDFchevron_right

Recombinant allergens for immunoblot diagnosis of tree-pollen allergy

Reinhold Hirschwehr

Journal of Allergy and Clinical Immunology, 1991

View PDFchevron_right

Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen

Reinhold Hirschwehr

Journal of Allergy and Clinical Immunology, 1997

View PDFchevron_right

Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms

Milena Weber

Journal of Allergy and Clinical Immunology, 2018

View PDFchevron_right

Association of allergic patients’ phenotypes with IgE reactivity to recombinant pollen marker allergens

Ines Swoboda

Allergy, 2010

View PDFchevron_right

Recombinant allergens for immunoblot diagnosis of tree-pollent allergy

Michael Breitenbach

Journal of Allergy and Clinical Immunology, 1991

View PDFchevron_right

Induction and regulation of allergen-specific IgE

Huub Savelkoul

View PDFchevron_right

Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome

Wolf-Meinhard Becker

Clinical & Experimental Allergy, 1999

View PDFchevron_right